Phathom Pharmaceuticals (PHAT) announced that Steven Basta has been appointed President and Chief Executive Officer and a member of the Board of Directors, effective immediately. Basta succeeds Terrie Curran, who is stepping down as President and CEO and as a member of the Board of Directors for personal reasons.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHAT:
- Phathom Pharmaceuticals partners with Kenan Thompson for GERD awareness
- Biotech Alert: Searches spiking for these stocks today
- Phathom Pharmaceuticals: Favorable Risk/Reward Profile Amid Challenges and Growth Opportunities
- Phathom Pharmaceuticals price target lowered to $13 from $17 at Jefferies
- Closing Bell Movers: Harrow spikes 24% on revenue beat, leverage update